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I t is well known that patients with type 2 diabetes are susceptible to various complications and have a 
poor health status,  leading to substantially higher mor-
tality compared to that of people without diabetes.  A 
relatively close association between diabetes and 
depression is known [1 , 2],  and the complication of 
depression is recognized to have deleterious conse-
quences in patients with diabetes.  In investigations of 
adult diabetic patients,  approx.  40% of the patients had 
depressive symptoms [2 , 3],  and another study showed 
that in diabetic patients,  the presence of a comorbid 
disorder can further increase the incidence of depres-
sion [4].
Depressive symptoms are also related to the deterio-
ration of diabetic symptoms including poor glycemic 
control,  impaired physical functioning,  and lowered 
quality of life [5 , 6].  The existence of clinical relation-
ships between depression and diabetic complications 
(e.g.,  neuropathy,  nephropathy,  and retinopathy) has 
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A relationship between diabetes and depression is apparent.  To clarify the clinical relevance of diabetic patients’ 
gastroesophageal symptoms to their psychological status,  we retrospectively analyzed the data from a Self-
rating Depression Scale (SDS) and a Frequency Scale for Symptoms of Gastroesophageal reflux disease (FSSG) 
among 143 type 2 diabetic patients who visited a general medicine department.  Among the 45 Japanese 
patients enrolled,  the group with relatively high SDS scores (≥ 36) showed higher (FSSG) dysmotility symptom 
scores versus the low-SDS (< 36) group,  although the 2 groups’ characteristics and laboratory data were not sig-
nificantly different.  Positive correlations of postprandial plasma glucose (PPG) levels with FSSG scores 
(R= 0.321,  p< 0.05),  particularly with reflux scores (R= 0.455,  p< 0.01) were revealed.  PPG and HbA1c levels 
were not correlated with SDS scores.  The patients’ SDS scores were significantly correlated with their FSSG 
scores (R= 0.41,  p< 0.01),  suggesting that depressive status is linked to GERD-related manifestations.  
Considering that the patients’ PPG levels were correlated with GERD-related symptoms,  diabetic patients’ 
blood glucose levels are associated with depressive status.  Collectively,  key symptoms related to GERD and 
glucose level values would be helpful for determining the psychological status of diabetic patients complaining 
of various uncertain symptoms.
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also been reported [7].  Depression was reported to 
remain undetected in more than half of all patients with 
depression in primary care settings,  and only about half 
of those with detected depression receive treatment [8].  
Therefore,  alternative strategies for detecting comorbid 
depression in patients with diabetes are important to 
prevent a progressive diabetic condition and subse-
quent complications.
The prevalence of gastroesophageal reflux disease 
(GERD) has been increasing worldwide [9].  GERD is 
associated with an impairment of the quality of life,  
esophageal carcinogenesis,  and lifestyle-related diseases 
including metabolic disorders and obesity [10].  The 
Self-rating Depression Scale (SDS) is widely used for 
assessing the severity of depression [11 , 12],  and the 
Frequency Scale for Symptoms of Gastroesophageal 
reflux disease (FSSG) is commonly used to assess the 
symptoms of GERD [13].  We conducted the present 
study to clarify the potential relationships among phys-
ical conditions,  laboratory data,  and psychological 
states assessed by using the SDS scores and FSSG scores 
obtained by patients with type 2 diabetes who visited 
outpatient general medicine departments.
We analyzed the correlations of SDS and FSSG 
scores with biochemical markers in patients with type 2 
diabetes,  and our findings will help predict latent psy-
chological conditions in diabetic patients who visit 
departments of general medicine with various unidenti-
fied complaints.
Patients and Methods
Patients. We retrospectively analyzed the epide-
miologic records of 143 patients with type 2 diabetes 
who had visited the Department of General Medicine in 
Okayama University Hospital (45 patients) or Okayama 
City Hospital (98 patients) during the period from Sept. 
1, 2016 to Aug. 31, 2018.  Eighty patients including 24 
patients at Okayama University Hospital (OUH) and 56 
patients at Okayama City Hospital (OCH) who had 
been taking a proton-pump inhibitor (PPI) were 
excluded since the use of a PPI can affect the FSSG 
scores.  Nine patients (3 at OUH and 6 at OCH) who 
had been taking an antidepressant were also excluded 
since antidepressants can affect the SDS score.  Three 
patients at OUH who refused participation in this study 
were also excluded.  Fifty-one patients (15 at OUH and 
36 at OCH) were found to be eligible and were included 
in this study,  and their SDS and FSSG scores were 
obtained twice with a 6-month interval.
After the exclusion of 6 patients with insufficient 
medical records,  the data of a total of 45 Japanese 
patients with type 2 diabetes (13 patients at OUH and 
32 patients at OCH) were included in this study (Fig. 1).  
Regarding the SDS scores obtained twice from each 
patient,  we selected the higher of the two SDS scores 
plus the time points corresponding to these higher SDS 
scores for our further analyses of various other clinical 
parameters.  The protocol of this study (KEN-1608-20) 
was approved by the Institutional Review Board of 
Okayama University Graduate School of Medicine,  
Dentistry and Pharmaceutical Sciences.
Scoring of the SDS and FSSG. Outpatients who 
visit our departments have been routinely asked to 
complete questionnaires including an SDS question-
naire designed to assess the respondent’s depressive 
status [11] and an FSSG questionnaire to assess GERD 
symptoms [13].  The SDS questionnaire has 20 items 
with scales rating the 4 common characteristics of 
depression [12]: pervasive effect,  physiological equiva-
lents,  other disturbances,  and psychomotor activities.  
There are 10 positively worded and 10 negatively 
worded questions.  The SDS has been recognized as a 
representative scale for clarifying depression status,  
with a score of ≥ 60 indicating a depressive condition 
[14].  The average SDS score for Japanese patients with 
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All patients with type 2 diabetes (n=143):
at Okayama University Hospital (n=45)
at Okayama City Hospital (n=98)
51 cases participated: 
SDS and FSSG examined twice with a 6-month interval 
Taking PPI (n=80)
Taking antidepressant (n=9)
Refused (n=3)
exclusion
Insuﬃcient records (n=6)
exclusion
Total of 45 cases analyzed:
at Okayama University Hospital (n=13)
at Okayama City Hospital (n=32)
???? ?　 Selection of study patients.  Data for all of the 143 
patients from Okayama University Hospital (n＝45) and from 
Okayama City Hospital (n＝98) were obtained from medical 
records.  Patients who had been taking a PPI (n＝80) or an antide-
pressant (n＝9),  3 patients who refused participation in the study,  
and 6 patients whose records were insuﬃcient were excluded.  The 
data of the remaining 45 patients were analyzed.
chronic disease have been reported to be around 36 
[15 , 16].  The FSSG questionnaire consists of 12 ques-
tions: seven assessing acid reflux symptoms and five 
assessing dysmotility-related symptoms.  An FSSG score 
of ≥ 8 has generally been considered to indicate proba-
ble GERD [13].
Statistical analyses. The data were analyzed by 
the Mann-Whitney U-test,  chi-squared test,  and Fisher’s 
exact test to determine significant differences between 
groups.  We also analyzed the data by performing a lin-
ear regression analysis and by obtaining the Spearman’s 
rank correlation coefficients in order to determine rela-
tionships between parameters.  Probability (p)-values 
< 0.05 were considered significant.  All statistical analy-
ses were performed using EZR (Saitama Medical 
Center,  Jichi University,  Saitama,  Japan),  a graphical 
user interface for R (The R Foundation for Statistical 
Computing,  Vienna,  Austria,  ver. 3.5.2) [17].
Results
Patients’ characteristics. Table 1 summarizes the 
characteristics of the 45 patients divided into those with 
an SDS score of < 36 (n = 30; the low-SDS group) and 
those with an SDS score of ≥ 36 (n = 15; the high-SDS 
group).  The higher of the two SDS scores for each 
patient was used for the analysis.  There were no signif-
icant differences between the low- and high-SDS groups 
concerning their characteristics,  including age,  gender,  
weight,  body mass index,  blood pressure,  number of 
diabetic complications (including retinopathy,  neurop-
athy,  nephropathy,  macro-vascular diseases,  hyperten-
sion and hyperlipidemia, ) number of medications used,  
or marital status.  Of note,  the FSSG scores were higher 
in the high-SDS group,  and this group’s scores showing 
dysmotility symptoms rather than reflux symptoms 
were significantly (p < 0.05) increased compared to those 
of the low-SDS group.
There were also no significant differences between 
the low- and high-SDS groups in any of the laboratory 
data,  i.e.,  the hemoglobin concentration,  hematocrit,  
serum levels of electrolytes (sodium and potassium),  
protein (total protein and albumin),  lipids (low-density 
lipoprotein cholesterol,  high-density lipoprotein cho-
lesterol,  and triglyceride),  liver enzymes (aspartate 
aminotransferase,  alanine aminotransferase and γ-glu-
tamyl transpeptidase),  the levels of renal function 
markers (blood urea nitrogen,  creatinine and estimated 
glomerular filtration rate),  and the postprandial plasma 
glucose (PPG) and hemoglobin A1c (HbA1c) levels.
The relationships between SDS and FSSG scores and 
diabetic parameters. Figure 2 illustrates the rela-
tionships between SDS scores and diabetic parameters,  
including the correlations between HbA1c levels and 
SDS scores (Fig. 2A) and between PPG and SDS scores 
(Fig. 2B).  In all 45 of the patients analyzed (Fig. 2A),  
the SDS score was not significantly correlated with the 
level of HbA1c (%).  As shown in Fig. 2B,  the SDS score 
was also not significantly correlated with the level of 
PPG (mg/dl).  Figure 3 shows the relationships between 
FSSG scores and diabetic parameters.  The FSSG score 
was significantly correlated with the PPG level 
(R = 0.321,  p < 0.05) (Fig. 3B) but not significantly cor-
related with the HbA1c level (Fig. 3A).  The FSSG-reflux 
score (R = 0.455,  p < 0.01) (Fig. 3C) but not the FSSG-
dysmotility score (Fig. 3D) was significantly correlated 
with the PPG level.
Correlations between SDS and FSSG scores.
Figure 4 provides the results of the linear regression 
analysis performed to determine the correlations 
between the patients’ SDS and FSSG scores.  A signifi-
cant correlation was revealed between the FSSG and 
SDS scores (R= 0.41,  p< 0.01).  The SDS scores were also 
correlated with the FSSG-reflux scores (R = 0.37,  
p < 0.05) (Fig. 4B) and with the FSSG-dysmotility scores 
(R = 0.444,  p < 0.01) (Fig. 4C).
Discussion
Our present analyses revealed for the first time that 
PPG was a key factor causing GERD-related symptoms 
in patients with type 2 diabetes mellitus.  It is notewor-
thy that the patients’ FSSG scores were significantly 
correlated with their PPG levels but not significantly 
correlated with their HbA1c levels.  In this regard,  Fan 
et al.  reported the relationship between esophageal 
reflex exposure and gastric acidity in patients with 
GERD,  and they demonstrated that their patients’ gas-
tric pH levels were transiently increased 1 h after food 
intake,  whereas the patients’ postprandial esophageal 
reflex exposures were thereafter significantly intensified 
[18].  Horowitz et al.  reported that the phenomenon of 
delayed gastric emptying is also related to increased 
PPG [19].  It is thus possible that the body’s PPG level 
(which is changed by food intake),  as opposed to the 
HbA1c level (which reflects the average blood glucose 
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level of the past few months [20]) is substantially cor-
related with gastric emptying and/or gastric pH,  lead-
ing to GERD symptoms.
The results of our present analyses demonstrated 
that the patients with diabetes who had relatively high 
SDS scores (≥ 36) had a higher frequency of dysmotili-
ty-induced symptoms compared to the patients with low 
SDS scores.  Since parameters for depression were sig-
nificantly correlated with the FSSG scores,  it appears 
that depressive status is closely linked to the manifesta-
tion of GERD-related symptoms.  In this regard,  we 
recently reported the existence of positive correlations 
between FSSG and SDS scores regardless of individual 
chief complaints [21].  In that study,  the FSSG-
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????? ?　 Comparison of patientsʼ proﬁle and clinical and laboratory parameters
SDS groups SDS score ＜36(n＝30)
SDS score ≥36
(n＝15) P value
Patientʼs proﬁle
　Age [years] 61.6 (2.16) 62.6 (2.48) 0.99
　Gender [male % (n)/female % (n)] 70.0 (21)/30.0 (9) 53.3 (8)/46.7 (7) 0.441
　Weight [kg] 69.4 (2.89) 65.0 (2.93) 0.571
　BMI [kg/m2] 25.5 (0.68) 25.5 (1.25) 0.709
　SBP [mmHg] 134.2 (2.76) 133.3 (3.83) 0.962
　DBP [mmHg] 76.7 (2.28) 78.3 (2.42) 0.838
　Number of complications 2.4 (0.28) 3.1 (0.43) 0.165
　Number of medications 4.4 (0.36) 4.4 (0.49) 0.741
　Marital status [married % (n)/unmarried % (n)] 73.3 (22)/26.7 (8) 73.3 (11)/26.7 (4) 1
FSSG score
　Reﬂux symptoms 1.5 (0.34) 2.9 (0.76) 0.142
　Dysmotility symptoms 1.6 (0.30) 3.0 (0.57) ＊0.0263
　Total 3.1 (0.57) 5.9 (1.29) 0.061
Laboratory data
　Hb [g/dL] 14.4 (0.29) 13.9 (0.36) 0.638
　Ht [%] 42.8 (0.73) 41.6 (1.12) 0.523
　TP [g/dL] 7.1 (0.07) 6.9 (0.14) 0.205
　Alb [g/dL] 4.3 (0.05) 4.0 (0.11) 0.109
　Na [mEq/L] 140.5 (0.34) 140.8 (0.54) 0.733
　K [mEq/L] 4.4 (0.07) 4.4 (0.09) 0.923
　AST [IU/L] 23.9 (1.58) 22.5 (2.12) 0.405
　ALT [IU/L] 28.5 (2.86) 22.6 (2.81) 0.311
　γGTP [IU/L] 48.1 (8.92) 31.1 (6.02) 0.492
　BUN [mg/dL] 14.7 (0.73) 16.6 (1.53) 0.282
　Cr [mg/dL] 0.81 (0.03) 0.93 (0.17) 0.47
　eGFR [mL/m/1.73m2] 72.2 (3.11) 66.1 (7.32) 0.639
　LDL-C [mg/dL] 103.4 (3.98) 106.1 (8.52) 0.819
　HDL-C [mg/dL] 57.5 (3.38) 50.7 (3.43) 0.341
　TG [mg/dL] 147.3 (14.51) 144.6 (13.14) 0.656
　PPG [mg/dL] 142.1 (6.77) 154.4 (10.64) 0.42
　HbA1c [%] 7.0 (0.13) 6.9 (0.28) 0.885
Values are shown as mean (SEM) or % (n) and were statistically analyzed by the Mann-Whitney U-test,  chi-squared test and Fisherʼs exact 
test.  Signiﬁcant level was set at ＊p＜0.05.
BMI,  body mass index; SBP,  systolic blood pressure; DBP,  diastolic blood pressure; Hb,  hemoglobin; Ht,  hematocrit; TP,  total pro-
tein; Alb,  albumin; Na,  sodium; K,  potassium; AST,  aspartate aminotransferase; ALT,  alanine aminotransferase; γGTP,  γ-glutamyl 
transpeptidase; BUN,  blood urea nitrogen; Cr,  creatinine; eGFR,  estimated glomerular ﬁltration rate ＝194×creatinine-1.094 ×age-0.287;  
LDL-C,  low-density lipoprotein cholesterol; HDL-C,  high-density lipoprotein cholesterol; TG,  triglyceride; PPG,  postprandial plasma glu-
cose; and HbA1c,  hemoglobin A1c.
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???? ?　 The relationship between blood glucose levels and FSSG scores.  The correlations of the patientsʼ HbA1c values and their FSSG 
scores (A) and the correlations of their PPG values with their FSSG scores (B) are shown.  The FSSG scores showed a signiﬁcant positive 
correlation with the PPG levels (R＝0.321,  ＊p＜0.05).  The correlations of PPG levels with the scores for acid-reﬂux symptoms (C) and 
dysmotility symptoms (D) are shown.  The acid-reﬂux symptom scores showed a signiﬁcant positive correlation with the PPG levels (R＝
0.455,  ＊＊p＜0.01).  The data were analyzed by a linear regression analysis.
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???? ?　 The relationship between blood glucose levels and the SDS scores.  Correlations between the patientsʼ HbA1c levels and SDS 
scores (A) and between their PPG values and SDS scores (B) are shown.  The data were analyzed by a linear regression analysis.
dysmotility score had a stronger positive correlation 
than the FSSG-reflux score with the SDS score,  and this 
result is in agreement with our present findings for 
patients with type 2 diabetes.
The FSSG questionnaire has five items regarding 
gastrointestinal dysmotility symptoms that are related to 
functional dyspepsia (FD),  which is characterized by 
chronic symptoms of recurrent postprandial fullness,  
early satiety,  and epigastric discomfort despite the 
absence of any endoscopic abnormality [22].  The possi-
bility of various latent esophageal diseases was not com-
pletely excluded by endoscopic examination in the 
present study; however,  the tendency of a high FSSG-
dysmotility score may reflect the prevalence of FD.  
Since mental conditions such as depression and anxiety 
can be causes of the manifestation of FD [23 , 24],  it is 
possible that depressive status is related to high FSSG-
dysmotility scores induced by FD-related symptoms.  
Considering that our patients’ PPG levels were cor-
related with GERD-related symptoms,  the levels of 
blood glucose are indirectly but potentially involved in 
the depressive status in patients with type 2 diabetes.
Regarding GERD symptoms in diabetic patients,  a 
study of Japanese patients showed that 23% of the 
patients had an FSSG score of ≥ 8 and,  interestingly,  
the same study indicated that the coexistence of meta-
bolic syndrome and a low level of serum adiponectin 
was associated with GERD symptoms [25].  Adiponectin 
is presumed to be a protective factor against erosive 
esophagitis,  since adiponectin is known to suppress 
inflammation in various organs [26].  From the clinical 
point of view,  an antidiabetic agent such as thiazolidine 
derivatives (which are known to increase serum adi-
ponectin) might be effective for patients with type 2 
diabetes and GERD symptoms.  In order to clarify the 
involvement of adiponectin in the development of 
GERD in diabetic patients,  we would like to investigate 
the effects of thiazolidine on serum adiponectin levels in 
relation to the clinical symptoms of GERD in a future 
prospective study.
From another viewpoint,  the relevance of GERD-
related symptoms was shown in patients with male 
andropause [27] who were suffering from erectile dys-
function (ED),  decreased muscle strength,  metabolic 
syndrome with obesity,  osteoporosis,  and depression 
due to a decreased level of male testosterone,  i.e.,  the 
so-called late-onset hypogonadism (LOH) syndrome.  
In an earlier study by our group,  the subjects’ FSSG 
scores were inversely correlated with their serum free 
testosterone levels,  implying that a medical interview 
regarding GERD symptoms is a critical step for detect-
ing LOH [27].  The relevance of depressive symptoms to 
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???? ?　 The relationship between SDS and FSSG scores.  The correlations of SDS and FSSG scores including reﬂux-symptom scores 
and dysmotility-symptom scores are shown.  A,  The patientsʼ total SDS scores showed a signiﬁcant positive correlation with the total FSSG 
scores (R＝0.41,  ＊＊p＜0.01); B,  The patientsʼ SDS scores also showed signiﬁcant positive correlations with the FSSG acid-reﬂex symp-
tom scores (R＝0.37,  ＊p＜0.05) and with (C) the FSSG dysmotility symptom scores (R＝0.444,  ＊＊p＜0.01).  The data were analyzed 
by a linear regression analysis.
the prevalence of ED has also been reported in Japanese 
males with type 2 diabetes [28],  in whom overweight 
status seemed to be involved in both ED and lowered 
testosterone.  Thus,  a determination of the FSSG scores 
would be helpful for detecting psychological conditions 
related to latent complications in male diabetic patients.
Patients with type 2 diabetes have been reported to 
have a higher prevalence of depressive symptoms com-
pared to the prevalence that in the general population 
[3 , 29 , 30].  It was also reported that the association 
between depressive symptoms and the occurrence of 
type 2 diabetes was independent of obesity,  habitual 
and physical activities,  chronic medical conditions,  
and family history [31].  However,  moderate to severe 
levels of depression at baseline seem to be critical for the 
late occurrence of type 2 diabetes [31].
It has been suggested that depressive disorders are 
accompanied by increased sympatho-adrenal system 
activity [32 , 33] as measured by the level of catechol-
amine,  which is known to facilitate an increase in blood 
glucose [34].  Depressive disorders have also been 
shown to be involved in dysregulation of the hypothal-
amo-pituitary adrenal (HPA) axis [35],  leading to 
impaired glucose tolerance [34].  Underlying endocrine 
dysregulation related to depressive status might there-
fore also be involved in the deterioration of diabetic 
control.
Collectively,  the above-described previous findings 
and our present results show mutual relationships 
among the blood glucose level,  GERD,  and depressive 
state in individuals with diabetes (Fig. 5).  We observed 
that increased blood glucose levels were correlated with 
GERD-related symptoms,  whereas the glucose levels 
were not directly correlated with depressive status as 
assessed by the SDS.  Since FSSG scores,  including both 
reflux and dysmotility scores,  are positively correlated 
with SDS scores,  increased blood glucose may indi-
rectly cause the manifestation and/or progress of the 
depressive status in patients with type 2 diabetes (Fig. 5).
A further multicenter study with a large population 
is necessary to confirm the findings of this study.  Our 
findings indicate that key symptoms related to GERD 
and the blood glucose value are useful for predicting 
depressive status in diabetic patients who visit general 
medicine departments with various uncertain symp-
toms.
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